Form 8-K - Current report:
SEC Accession No. 0000950170-24-104915
Filing Date
2024-09-10
Accepted
2024-09-10 07:01:18
Documents
11
Period of Report
2024-09-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K acet-20240910.htm   iXBRL 8-K 41805
  Complete submission text file 0000950170-24-104915.txt   157163

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240910.xsd EX-101.SCH 25037
14 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240910_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241288730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)